Trials / Sponsors / Alethia Biotherapeutics
Alethia Biotherapeutics
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liv Metastatic Colorectal Cancer | Phase 2 | 2024-02-15 |
| Completed | AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002) NSCLC Stage IV | Phase 2 | 2021-02-23 |
| Completed | Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy Solid Tumor, Metastatic Cancer | Phase 1 | 2015-04-01 |